Expression of ErbB-1 and 2 in vestibular schwannomas

Journal of Clinical Neuroscience

Volumn 14, Issue 12, 2007, Pages 1199-1206

  Wickremesekera, Agadha ^a   Hovens, Christopher M ^b   Kaye, Andrew H ^b  

^a WELLINGTON HOSPITAL   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Benign tumourigenesis; ErbB 2; Vestibular schwannoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; NEURILEMOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VESTIBULAR SYSTEM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELLS, CULTURED; CRANIAL NERVE NEOPLASMS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICE; NEOPLASM PROTEINS; NEUROMA, ACOUSTIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 36049021784     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.05.009     Document Type: Article

References (37)

1. Groenen L.C., Nice A.W., and Burgess C.E. Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors 11 (1994) 235-257
2. Toyoda H., Komurasaki T., Uchida D., et al. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 270 (1995) 7495-7500
3. Songyang Z., Shoelson S.E., Chaudhuri M., et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72 (1993) 767-778
4. Lonardo F., Di Marco E., King C.R., et al. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol 2 (1990) 992-1003
5. Pinkas-Kramarski R., Shelly M., Glathe S., et al. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. J Biol Chem 271 (1996) 19029-19032
6. Goldman R., Levy R.B., Peles E., et al. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 29 (1990) 11024-11028
7. Riese II D.J., van Raaij T.M., Plowman G.D., et al. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol 15 (1995) 5770-5776
8. Wada T., Qian X.L., and Greene M.I. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 61 (1990) 1339-1347
9. Kokai Y., Myers J.N., Wada T., et al. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58 (1989) 287-292
10. Alimandi M., Romano A., Curia M.C., et al. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10 (1995) 1813-1821
11. Tzahar E., and Yarden Y. The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim Biophys Acta 1377 (1998) M25-M37
12. Ben-Levy R., Paterson H.F., Marshall C.J., et al. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J 13 (1994) 3302-3311
13. Klapper L.N., Vaisman N., Hurwitz E., et al. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene 14 (1997) 2099-2109
14. Graus-Porta D., Beerli R.R., Daly J.M., et al. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16 (1997) 1647-1655
15. Cohen B.D., Kiener P.A., Green J.M., et al. The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J Biol Chem 271 (1996) 30897-30903
16. Fernandez-Valle C., Tang Y., Ricard J., et al. Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet 31 (2002) 354-362
17. Hansen M.R., and Linthicum Jr. F.H. Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation. Otol Neurotol 25 (2004) 155-159
18. Sobel R.A. Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases. J Neuropathol Exp Neurol 52 (1993) 106-113
19. Briggs R.J., Brackmann D.E., Baser M.E., et al. Comprehensive management of bilateral acoustic neuromas. Current perspectives. Arch Otolaryngol Head Neck Surg 120 (1994) 1307-1314
20. Downward J., Yarden Y., Mayes E., et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307 (1984) 521-527
21. Wikstrand C.J., Hale L.P., Batra S.K., et al. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res 55 (1995) 3140-3148
22. Carroll R.S., Black P.M., Zhang J., et al. Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 87 (1997) 315-323
23. Scoccia B., Lee Y.M., Niederberger C., et al. Expression of the ErbB family of receptors in ovarian cancer. J Soc Gynecol Investig 5 (1998) 161-165
24. Shiurba R.A., Eng L.F., Vogel H., et al. Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells. Cancer 62 (1988) 2139-2144
25. Jones N.R., Rossi M.L., Gregoriou M., et al. Epidermal growth factor receptor expression in 72 meningiomas. Cancer 66 (1990) 152-155
26. Jones N.R., Rossi M.L., Gregoriou M., et al. Investigation of the expression of epidermal growth factor receptor and blood group A antigen in 110 human gliomas. Neuropathol Appl Neurobiol 16 (1990) 185-192
27. Sturgis E.M., Woll S.S., Aydin E., et al. Epidermal growth factor receptor expression by acoustic neuromas. Laryngoscope 106 (1996) 457-462
28. Hynes N.E., and Stern D.F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198 (1994) 165-184
29. Schwechheimer K., Laufle R.M., Schmahl W., et al. Expression of neu/c-erbB-2 in human brain tumors. Hum Pathol 25 (1994) 772-780
30. Chow N.H., Chan S.H., Tzai T.S., et al. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. Clin Cancer Res 7 (2001) 1957-1962
31. Chozick B.S., Benzil D.L., Stopa E.G., et al. Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas. J Neurooncol 27 (1996) 117-126
32. Gerdin E., Juhlin C., Malmgren M., et al. Immunohistochemical identification of receptors for epidermal growth factor in tumor endothelium may be affected by cross-reactivity to blood group A antigen. Am J Clin Pathol 99 (1993) 28-31
33. Salomon D.S., Brandt R., Ciardiello F., et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19 (1995) 183-232
34. Graus-Porta D., Beerli R.R., and Hynes N.E. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol Cell Biol 15 (1995) 1182-1191
35. Karunagaran D., Tzahar E., Beerli R.R., et al. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 15 (1996) 254-264
36. Weiner D.B., Liu J., Cohen J.A., et al. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 339 (1989) 230-231
37. Hansen M.R., Roehm P.C., Chatterjee P., et al. Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation. Glia 53 (2006) 593-600